XML 24 R33.htm IDEA: XBRL DOCUMENT
v2.4.0.8

License and Collaboration Agreements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
License, Collaboration and Other Revenue | In accordance with our collaboration agreements, we recognized license, collaboration and other revenue as follows (in thousands):
|  |  |  | Year Ended December 31, |
Partner |  | Agreement |  | 2013 |  |  | 2012 |  |  | 2011 |
AstraZeneca AB |  | Naloxegol (NKTR-118) and naloxegol fixed-dose combination program (NKTR-119) |  | $ | 25,016 |  |  | $ | 59 |  |  | $ | 2,496 |
Roche |  | PEGASYS® and MIRCERA® |  |  | 18,382 |  |  |  | 7,146 |  |  |  | 5,131 |
Bayer Healthcare LLC |  | BAY41-6551 (Amikacin Inhale) |  |  | 15,293 |  |  |  | 2,971 |  |  |  | 2,992 |
Affymax, Inc. |  | OMONTYS® |  |  | 7,149 |  |  |  | 2,829 |  |  |  | 3,838 |
Amgen, Inc. |  | Neulasta® |  |  | 5,035 |  |  |  | 5,000 |  |  |  | 5,000 |
Baxter Healthcare |  | BAX 855 (Hemophilia) |  |  | 1,702 |  |  |  | 6,238 |  |  |  | 5,646 |
Other |  |  |  |  | 8,295 |  |  |  | 5,884 |  |  |  | 11,186 |
License, collaboration and other revenue |  |  |  | $ | 80,872 |  |  | $ | 30,127 |  |  | $ | 36,289 |

X
- Definition License collaboration and other revenue. + References No definition available. + Details
Name: | nktr_LicenseCollaborationAndOtherRevenueTableTextBlock
Namespace Prefix: | nktr_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration